FDA Approves First Pill to Treat Moderate-to-Severe Crohn ' s Disease

FRIDAY, May 19, 2023 -- Patients with Crohn ’s disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib). Rinvoq is meant to treat adults with moderately to severely active...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news